Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Current Opinion in Hematology|October 4, 2008
Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignanciesCraig Sauter, Juliet N Barker
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2008
Pentostatin in chronic lymphocytic leukemiaCraig Sauter, Nicole Lamanna, Mark A Weiss
Hematology/Oncology Clinics of North America|November 19, 2011
Cellular therapies in acute lymphoblastic leukemiaJae H Park, Craig Sauter, Renier Brentjens
Cancer Journal (Sudbury, Mass.)|November 21, 2015
CD19-Targeted T Cells for Hematologic Malignancies: Clinical Experience to DateMarco L Davila, Craig Sauter, Renier Brentjens
Transplantation and Cellular Therapy|September 19, 2020
Outcomes of Autologous Hematopoietic Cell Transplantation in Diffuse Large B Cell Lymphoma Refractory to Firstline ChemoimmunotherapySusan Bal, Luciano J Costa, Craig Sauter, et al.
Blood Advances|January 24, 2019
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphomaNeha Mehta-Shah, Kimiteru Ito, Kurt Bantilan, et al.
Blood|October 29, 2020
Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?Nirav N Shah, Kwang W Ahn, Carlos Litovich, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 6, 2023
Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation PhaseHussein Awada, Adel Hajj Ali, Faiz Anwer, et al.
Blood|September 10, 2010
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytesJuliet N Barker, Ekaterina Doubrovina, Craig Sauter, et al.
Transplantation and Cellular Therapy|May 24, 2021
Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell TransplantationNatasia Rodriguez, Jasme Lee, Lisa Flynn, et al.
Pageof 6